AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120
Cheng-hui Yan,
Hai-Wei Liu,
Xiao-xiang Tian,
Jiayin Li,
Ye Ding,
Yi Li,
Zhu Mei,
Ming-Hui Zou and
Ya-ling Han ()
Additional contact information
Cheng-hui Yan: General Hospital of Northern Theater Command
Hai-Wei Liu: General Hospital of Northern Theater Command
Xiao-xiang Tian: General Hospital of Northern Theater Command
Jiayin Li: General Hospital of Northern Theater Command
Ye Ding: Georgia State University
Yi Li: General Hospital of Northern Theater Command
Zhu Mei: General Hospital of Northern Theater Command
Ming-Hui Zou: Georgia State University
Ya-ling Han: General Hospital of Northern Theater Command
Nature Communications, 2022, vol. 13, issue 1, 1-13
Abstract:
Abstract Consuming fish oils (FO) is linked to reduced risk of cardiovascular disease in certain populations. However, FO failed to exhibit therapeutic effects in some patients with cardiovascular disease. This study aimed to determine the possible reasons for the inconsistent effects of FO. AMP-activated protein kinase (AMPK) α2 is an important energy metabolic sensor, which was reported to involve in FO mediated regulation of lipid and glucose metabolism. In an in vivo study, FO administration significantly reduced the aortic lesions and inflammation in the Ldlr−/− mouse model of atherosclerosis, but not in Ldlr−/−/Prkaa2−/−and Ldlr−/−/Prkaa2−/−Sm22Cre mice. Mechanistically, inactivation of AMPKα2 increased the SUMOylation of the fatty acid receptor GPR120 to block FO-induced internalization and binding to β-arrestin. In contrast, activation of AMPKα2 can phosphorylate the C-MYC at Serine 67 to inhibit its trans-localization into the nuclei and transcription of SUMO-conjugating E2 enzyme UBC9 and SUMO2/3 in vascular smooth muscle cells (VSMCs), which result in GPR120 SUMOylation. In human arteries, AMPKα2 levels were inversely correlated with UBC9 expression. In a cohort of patients with atherosclerosis, FO concentrations did not correlate with atherosclerotic severity, however, in a subgroup analysis a negative correlation between FO concentrations and atherosclerotic severity was found in patients with higher AMPKα2 levels. These data indicate that AMPKα2 is required for the anti-inflammatory and anti-atherosclerotic effects of FO.
Date: 2022
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-022-34996-x Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34996-x
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-022-34996-x
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().